Clinical grading in chronic graft-versus-host disease: Is it time for change?

Leukemia and Lymphoma

Volumn 43, Issue 6, 2002, Pages 1211-1220

  Akpek, Görgün ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic; Classification; Grading; Graft versus host; GVHD; Prognosis

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZATHIOPRINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PENICILLIN G; PENTOSTATIN; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THALIDOMIDE; TUMOR NECROSIS FACTOR ANTIBODY;

BACTERIAL INFECTION; BLOOD DONOR; BODY SURFACE; CANCER CENTER; CANCER RECURRENCE; CANCER SURVIVAL; CHRONIC DISEASE; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; INCIDENCE; INFUSION; LEUKEMIA; LONG TERM CARE; LYMPHOCYTE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYCOSIS; PATIENT CODING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RELIABILITY; REPRODUCIBILITY; REVIEW; RISK FACTOR; SKIN DISEASE; THROMBOCYTOPENIA; TREATMENT OUTCOME; VALIDATION PROCESS; ALGORITHM; EYE; HOSPITALIZATION; LIVER; MINOR SALIVA GLAND; MOUTH MUCOSA; PATHOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SKIN; SURVIVAL;

ALGORITHMS; CHRONIC DISEASE; EYE; GRAFT VS HOST DISEASE; HUMAN; IMMUNOSUPPRESSIVE AGENTS; LIVER; MOUTH MUCOSA; MULTIVARIATE ANALYSIS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SALIVARY GLANDS, MINOR; SEVERITY OF ILLNESS INDEX; SKIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME; HUMANS;

EID: 0035992295     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290026268     Document Type: Review

References (37)

1. "Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years"
2. "Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers"
3. "Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle"
4. "A randomized trial of filgrastim (G-CSF) stimulated donor marrow (BM) versus peripheral blood (PBC) for allogeneic transplantation: Increased extensive chronic graft versus host disease following PBPC transplantation (abstract)"
5. "Long-term survival and late deaths after allogeneic bone marrow transplantation. Late effects working committee of the international bone marrow transplant registry"
6. "The importance of confirming graft versus host disease (GVHD) diagnosis (abstract)"
7. "Development of a prognostic model for grading chronic graft-versus-host disease"
8. "Chronic graft-versus-host disease review"
9. "Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression"
10. "Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: Prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation"
11. "Clonal analysis of murine graft-versus-host disease I. Phenotypic and functional analysis of T lymphocyte
12. "Minor histocompatibility antigens"
13. "Development of graft-versus-host disease-like syndrome in cyclosporine treated rats after syngeneic bone marrow transplantation. I. Development ant-Ia specificity, including autoreactivity"
14. "Specificity of effector T lymphocytes in autologous graft-versus-host disease: Role of the major histocompatibility complex class II invariant chain peptide"
15. "The pathophysiology of graft-versus-host disease"
16. "Graft-versus-host disease: The influence of type 1 and type 2 T cell cytokines"
17. "Graft-versus-host disease and the Th1/Th2 paradigm"
18. "Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation"
19. "Chronic graft versus host disease in other late complications of bone marrow transplantation"
20. "Graft-versus-host disease"
21. "Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation"
22. "Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-versus-host disease"
23. "How I treat chronic graft-versus-host disease"
24. "Predictors of death from chronic graft versus host disease after bone marrow transplantation"
25. "Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings"
26. "Chronic graft-versus host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients"
27. "Chronic graft-versus-host disease after allogeneic blood stem cell or bone marrow transplantation: Factors determining the onset and survival (abstract)"
28. "Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors"
29. "Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease"
30. "Cyclosporine A to prevent graft-versus-host disease" a pilot study in 22 patients receiving allogeneic marrow transplants"
31. "The histopathology of graft-versus-host disease"
32. "The lichen planus-like eruption after bone marrow transplantation"
33. "Graft-versus-host disease is associated with autoimmune-like thrombocytopenia"
34. "Chronic graft-versus-host disease (GVHD) following unrelated donor transplantation "
35. "Acute bleeding after allogeneic bone marrow transplantation: Association with graft versus host disease and effect on survival"
36. "Increased late complications of allogeneic and autologous marrow transplantation"
37. "Late infections after allogeneic bone marrow transplantation: Comparison of incidence in related and unrelated donor transplant recipients"